Reactions Weekly

, Volume 1769, Issue 1, pp 156–156 | Cite as


Rash and infusion related reaction: 3 case reports
Case report


  1. Lockhart A, et al. Rash developing after cessation of Daclizumab for relapsing remitting MS; a case series. Multiple Sclerosis and Related Disorders 35: 239-240, Oct 2019. Available from: URL: - IrelandCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations